Table 2.

General characteristics of the included studies.

Characteristics	Number of Studies	Reference Number
Year of publication
2021	n = 13	[38,39,40,43,45,46,47,48,49,50,51,52,53]
2020	n = 9	[13,35,37,41,42,44,54,55,56]
2019	n = 2	[36,57]
2018	n = 1	[58]
2017	n = 2	[59,60]
2015	n = 1	[61]
Country
Australia	n = 3	[36,49,59]
Belgium	n = 1	[42]
France	n = 1	[40]
Italy	n = 1	[54]
Norway	n = 2	[38,60]
Sweden	n = 3	[13,37,39]
The Netherlands	n = 1	[55]
USA	n = 14	[35,43,44,45,46,47,48,50,51,52,53,57,58,61]
Worldwide	n = 2	[41,56]
Methodology/type
Qualitative study—semi-structured interviews	n = 5	[36,37,39,51,59]
Qualitative study—Focus groups	n = 1	[60]
Web-based survey	n = 12	[13,38,40,41,43,44,48,50,53,54,56,61]
Randomized controlled trial	n = 1	[58]
Descriptive study	n = 1	[52]
Observational survey	n = 1	[55]
Mixed methods study	n = 5	[35,45,46,47,57]
Design thinking—customer journey	n = 1	[42]
Review	n = 1	[49]
Study participants
Mental health professionals	n = 8	[36,45,46,49,52,54,56,57]
Physicians	n = 15	[13,35,37,38,39,40,41,42,43,44,48,50,53,58,61]
Surgeons	n = 1	[55]
Nurses/nurse assistants/advanced practice professionals/residents/physical therapists/speech pathologists etc.	n = 8	[36,42,47,48,51,59,60,61]
Patients and/or caregivers	n = 7	[40,43,55,58,60,61]
Non-medical professionals (education staff, IT workers, social workers, care coordinators)	n = 4	[36,43,48,61]
Studies related to COVID-19 pandemic	n = 15	[35,36,40,41,42,43,44,45,46,47,48,49,50,52,54,56]